Allovir Inc (ALVR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 55,796 | 45,504 | 37,655 | 30,863 | 25,416 |
Operating Income | -55,796 | -45,504 | -37,655 | -30,863 | -25,416 |
Other Income | -1,138 | -6 | 67 | -60 | 217 |
Pre-tax Income | -56,934 | -45,510 | -37,588 | -30,923 | -25,199 |
Net Income Continuous | -57,941 | -45,510 | -37,588 | -30,923 | -25,199 |
Net Income | $-57,941 | $-45,510 | $-37,588 | $-30,923 | $-25,199 |
EPS Basic Total Ops | -0.92 | -0.72 | -0.60 | -0.50 | 6.63 |
EPS Basic Continuous Ops | -0.92 | -0.72 | -0.60 | -0.50 | 6.63 |
EPS Diluted Total Ops | -0.92 | -0.72 | -0.60 | -0.50 | 6.63 |
EPS Diluted Continuous Ops | -0.92 | -0.72 | -0.60 | -0.50 | 6.63 |
EBITDA(a) | $-55,702 | $-45,460 | $-37,622 | $-30,845 | $-25,398 |